3.20
price down icon3.61%   -0.12
 
loading
Precedente Chiudi:
$3.32
Aprire:
$3.3
Volume 24 ore:
1.70M
Relative Volume:
1.78
Capitalizzazione di mercato:
$227.34M
Reddito:
-
Utile/perdita netta:
$-117.81M
Rapporto P/E:
-1.7021
EPS:
-1.88
Flusso di cassa netto:
$74.30M
1 W Prestazione:
-0.31%
1M Prestazione:
+0.95%
6M Prestazione:
-72.60%
1 anno Prestazione:
-18.99%
Intervallo 1D:
Value
$3.17
$3.42
Intervallo di 1 settimana:
Value
$3.105
$3.596
Portata 52W:
Value
$2.97
$13.60

Omeros Corporation Stock (OMER) Company Profile

Name
Nome
Omeros Corporation
Name
Telefono
206-676-5000
Name
Indirizzo
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Name
Dipendente
202
Name
Cinguettio
@OmerosCorp
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
OMER's Discussions on Twitter

Confronta OMER con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OMER
Omeros Corporation
3.20 227.34M 0 -117.81M 74.30M -1.88
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Omeros Corporation Stock (OMER) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-10 Iniziato H.C. Wainwright Buy
2024-12-23 Iniziato D. Boral Capital Buy
2024-11-14 Iniziato Rodman & Renshaw Buy
2022-12-08 Downgrade UBS Buy → Neutral
2022-11-08 Downgrade BofA Securities Neutral → Underperform
2022-06-08 Downgrade BofA Securities Buy → Neutral
2021-10-08 Downgrade JP Morgan Neutral → Underweight
2021-10-01 Downgrade Maxim Group Buy → Hold
2021-10-01 Downgrade Wedbush Neutral → Underperform
2021-09-27 Iniziato JP Morgan Neutral
2021-02-01 Iniziato UBS Buy
2020-10-20 Iniziato BofA Securities Buy
2020-08-21 Reiterato H.C. Wainwright Buy
2020-08-14 Reiterato Maxim Group Buy
2019-05-06 Iniziato Cantor Fitzgerald Overweight
2018-07-12 Iniziato Seaport Global Securities Buy
2018-03-23 Downgrade Wedbush Outperform → Neutral
2018-03-05 Downgrade Needham Buy → Hold
2017-11-08 Iniziato H.C. Wainwright Buy
2017-05-11 Downgrade Cantor Fitzgerald Buy → Neutral
2017-03-17 Reiterato Maxim Group Buy
2017-03-17 Reiterato Needham Buy
2016-11-16 Reiterato Wedbush Outperform
2016-11-10 Reiterato Needham Buy
2016-08-10 Reiterato Maxim Group Buy
2016-06-03 Iniziato Cantor Fitzgerald Buy
2016-03-02 Reiterato Needham Buy
2016-02-29 Reiterato Wedbush Outperform
2015-11-11 Reiterato Needham Buy
2015-08-18 Reiterato WBB Securities Strong Buy
2015-08-10 Iniziato ROTH Capital Buy
Mostra tutto

Omeros Corporation Borsa (OMER) Ultime notizie

pulisher
Jun 16, 2025

Ratios Revealed: Decoding Omeros Corporation (OMER)’s Financial Health - DWinneX

Jun 16, 2025
pulisher
Jun 16, 2025

Omeros Co. (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 13, 2025

What is HC Wainwright’s Forecast for Omeros FY2025 Earnings? - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

HC Wainwright Predicts Omeros’ Q2 Earnings (NASDAQ:OMER) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Omeros (NASDAQ:OMER) Now Covered by Analysts at HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on Omeros FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Trend Tracker for (OMER) - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OME - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OMER Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

HC Wainwright Initiates Coverage on Omeros With Buy Rating, $9 Price Target - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Set for Growth with Potential Narsoplimab Approval - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Set for Growth with Potential Narsoplimab Approval | OMER Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program - mx.advfn.com

Jun 09, 2025
pulisher
Jun 08, 2025

Omeros (NASDAQ:OMER) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026 - mx.advfn.com

Jun 08, 2025
pulisher
Jun 08, 2025

OMEROmeros Corporation Reports First Quarter 2025 Financial Results - mx.advfn.com

Jun 08, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Has $316,000 Stake in Omeros Co. (NASDAQ:OMER) - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Millennium Management LLC Buys 27,088 Shares of Omeros Co. (NASDAQ:OMER) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Two Sigma Advisers LP Decreases Position in Omeros Co. (NASDAQ:OMER) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Omeros Corporation to Host Earnings Call - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

Nuveen Asset Management LLC Reduces Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Omeros Co. (NASDAQ:OMER) Shares Bought by Two Sigma Investments LP - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Down 54.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Omeros (OMER) - Yahoo Finance

Jun 03, 2025
pulisher
Jun 02, 2025

BNP Paribas Financial Markets Has $74,000 Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

ProShare Advisors LLC Has $183,000 Position in Omeros Co. (NASDAQ:OMER) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Omeros Corporation to acquire $80.5 million of its convertible senior notes due 2026 - MSN

Jun 01, 2025
pulisher
May 31, 2025

Deutsche Bank AG Has $396,000 Stock Holdings in Omeros Co. (NASDAQ:OMER) - Defense World

May 31, 2025
pulisher
May 28, 2025

Omeros' Note Swap Causes Share Price Tumble - Finimize

May 28, 2025
pulisher
May 27, 2025

Omeros: On The Brink As It Awaits Its Fall PDUFA For A Potential Blockbuster (OMER) - Seeking Alpha

May 27, 2025
pulisher
May 22, 2025

Equities Analysts Issue Forecasts for Omeros FY2025 Earnings - Defense World

May 22, 2025
pulisher
May 22, 2025

Omeros Co. (NASDAQ:OMER) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

May 22, 2025
pulisher
May 20, 2025

Omeros (NASDAQ:OMER) Rating Increased to Hold at StockNews.com - Defense World

May 20, 2025
pulisher
May 18, 2025

Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance - MSN

May 18, 2025
pulisher
May 18, 2025

Omeros (NASDAQ:OMER) Earns Hold Rating from Needham & Company LLC - Defense World

May 18, 2025
pulisher
May 17, 2025

Omeros Corporation (NASDAQ:OMER) Q1 2025 Earnings Call Transcript - Insider Monkey

May 17, 2025
pulisher
May 17, 2025

Omeros Co. (NASDAQ:OMER) Shares Purchased by Comerica Bank - Defense World

May 17, 2025
pulisher
May 16, 2025

Omeros Corp. Earnings Call: Cautious Optimism Amid Challenges - TipRanks

May 16, 2025
pulisher
May 16, 2025

Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic D - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Needham Reiterates Hold Rating on Omeros (OMER) | OMER Stock New - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: Omeros Q1 2025 sees stock rise post-earnings By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Omeros: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 16, 2025

Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab ... - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab Launch Plans - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Omeros (OMER) Achieves Milestone with FDA Acceptance of Narsopli - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Omeros Corporation Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: Omeros Q1 2025 sees stock rise post-earnings - Investing.com

May 16, 2025
pulisher
May 15, 2025

Omeros (OMER) Streamlines Debt, Preps for Narsoplimab Launch - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Transcript : Omeros Corporation, Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Omeros Corp Q1 2025 Earnings: EPS of -$0.58 Misses Estimates, Re - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Omeros reports Q1 EPS (58c), consensus (60c) - TipRanks

May 15, 2025

Omeros Corporation Azioni (OMER) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Capitalizzazione:     |  Volume (24 ore):